DXCOVER
It is our mission to be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Dxcover are an award-winning team, dedicated to developing liquid biopsies for early detection of cancer and other diseases. A University of Strathclyde spinout in 2019 under the name ClinSpec Diagnostics, and rebranded as Dxcover Limited in 2021. To date, Dxcover have secured ยฃ5.1m of funding, and have successfully completed two ground-breaking clinical studies on detection of brain cancer and are currently developing our platform for the detection of commonly occurring cancers.
DXCOVER
Industry:
Biotechnology Health Care Health Diagnostics Machine Learning Medical Medical Device
Founded:
2016-01-01
Address:
Glasgow, Glasgow City, United Kingdom
Country:
United Kingdom
Website Url:
http://www.dxcover.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
6.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content COVID-19 Wix
Similar Organizations
1928 Diagnostics
Fighting antibiotic resistance with DNA analytics
Abtrace
AI based solutions that scale medical expertise.
Aidence
Aidence provides AI solutions for the lung cancer pathway.
Aktiia
AI-driven insights for a novel understanding and care of Hypertension
Concepta Diagnostics
Women's Health Diagnostic Company
Concr
Solving data to enable precision diagnostics for all.
Czur scanner
The Czur is a sort of camera/scanner hybrid
D-EYE
D-EYE provides portable eye and retinal imaging system.
De Lune
The New Age of Period Health
Ectosense
Sleep disorder diagnostics
Elephas
A live tumor imaging diagnostics company
Expeda
Expeda produces quality medical bioinformatics diagnostic tools.
Fastbase Solutions
Fastbase Solutions is a cancer diagnostics platform.
Fourier Intelligence
Fourier Intelligence is a Technology and design company
GNA Biosolutions
GNA Biosolutions is a private molecular diagnostics company.
Hutom
Reshaping Surgery Through Digital Innovation
Ilara Health
Affordable technology-powered diagnostics for Africa
iLoF - Intelligent Lab on Fiber
iLoF - Intelligent Lab on Fiber is enabling a new era of personalized, precision medicine.
inContAlert Technologies
The hearing aid for incontinence.
Inno-Gene
The project of reading human genome
iXensor
The pioneer of mobile health
Kฤhu
Kฤhu is the Kiwi AI cancer-detection startup.
Lambda Health System
Lambda Health System is a spin-off of the University
Lucid Group
Lucid aims to develop a unique 3 in one diagnostic device.
Medical Imaging Partnership
UK-based provider of medical diagnostic imaging services.
MedicaMetrix
Advancing Prostate Disease Management
Moichor
The next generation of animal diagnostics.
Mologic
Mologic is a UK-based developer of point-of-care diagnostic devices
Mursla
Novel multi-omics exosome characterisation company.
NuProbe
NuProbe is a cutting-edge genomics and molecular diagnostics company.
Nutrix
Reshaping the future of healthcare
Omniscope
We read your immune system to intercept diseases.
Orange Health
Orange Health is a HealthTech startup that allows doctors to deliver diagnostic lab services to patients remotely.
Paige
A Global Leader in Digital Diagnostics
Pre Diagnostics
Pre Diagnostics is an innovative Norwegian diagnostic company
Protean BioDiganostics Inc
Precision Oncology and Diagnostics
Pulsewave
Pulsewave is transforming Eyewear into Cardio Biomarker monitoring wearables.
Quantum_AI Advanced Health-Care Solutions
The Future of Health-Care
QV Bioelectronics
Longer, Better Quality Lives for Brain Tumour Patients
RSP Systems A/S
Non-Invasive Glucose Monitoring and other Non-Invasive Diagnostics
Sanome
Transforming diagnostics for all
Scanbo
Democratizing Access To Medical Diagnostics
Mediktor
The most advanced and accurate sypmtom checker
Wecancer
Wecancer provides a monitoring platform for cancer patients.
Current Employees Featured
Founder
Investors List
University of Strathclyde
University of Strathclyde investment in Seed Round - Dxcover
Norcliffe Capital
Norcliffe Capital investment in Seed Round - Dxcover
Eos Advisory
Eos Advisory investment in Seed Round - Dxcover
Eos Advisory
Eos Advisory investment in Seed Round - Dxcover
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - Dxcover
Mercia Asset Management
Mercia Asset Management investment in Seed Round - Dxcover
University of Strathclyde
University of Strathclyde investment in Seed Round - Dxcover
SIS Ventures
SIS Ventures investment in Seed Round - Dxcover
Scottish Investment Bank
Scottish Investment Bank investment in Seed Round - Dxcover
Mercia Fund Managers
Mercia Fund Managers investment in Seed Round - Dxcover
Official Site Inspections
http://www.dxcover.com
- Host name: 231.107.209.35.bc.googleusercontent.com
- IP address: 35.209.107.231
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Dxcover"
About Us - Dxcover
Dxcover Limited. Suite RC534, Royal College Building. 204 George Street. Glasgow G1 1XW ...See details»
Meet the Team - Dxcover
To be a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life. Inventor with 20+ yearsโ experience in โฆSee details»
Dxcover - Wikipedia
Dxcover has developed 'Drop, Dry, Detect' technology which technically detects and works in minutes to detect signs of cancer using artificial intelligence trained model. Panoramic platform is a multi-omic spectral analysis (MOSA) technology for various cancers which are brain, advanced adenoma, colorectal, and lung cancer. This technology analyses the signals that were missed by traditional cancer detection methods. See details»
Dxcover - Crunchbase Company Profile & Funding
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers. Dxcover may be growing as evidenced by the company's expansion of โฆSee details»
Dxcover - LinkedIn
Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes.See details»
Dxcover - Org Chart, Teams, Culture & Jobs - The Org
View Dxcover's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Dxcover Limited | Scientist.com
DXCOVER is a multi-omic clinical stage liquid biopsy company developing tests for the early detection of multiple solid tumor cancers and other diseases, when treatment has a better โฆSee details»
Dxcover - Updates, News, Events, Signals & Triggers - Crunchbase
Dxcover may be growing as evidenced by the company's expansion of its network in Europe and the USA, which indicates a broadening operational footprint. The firm has also announced โฆSee details»
Dxcover - Company Profile - Tracxn
Oct 4, 2024 Dxcover - AI-powered device for earlier diagnosis of brain tumors. Raised a total funding of $9.25M over 3 rounds from 9 investors. Founded by Mark Hegarty and Matthew J โฆSee details»
Investors - Dxcover
Dxcover Limited owns all the IP and has patents granted in the USA, Europe, and China for the detection of all types of cancer. Huge market potential Cancer is the fastest growing segment โฆSee details»
Dxcover Awarded First Prize for Poster at ESMO 2023 With Multi โฆ
GLASGOW, Scotland, October 25, 2023--Dxcover Limited, a clinical-stage liquid biopsy company pioneering Multi-Omic Spectral Analysis for early detection of cancer, today announced that it โฆSee details»
Dxcover Company Profile 2024: Valuation, Funding & Investors
Dxcover General Information Description. Provider of liquid biopsy equipment intended to detect cancer and other diseases early. The company combines infrared spectroscopy with artificial โฆSee details»
Dxcover - Contacts, Employees, Board Members, Advisors & Alumni
Dxcover is a cancer diagnostics startup that uses liquid biopsy and artificial intelligence for early diagnosis of cancers. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. โฆSee details»
Dxcover Raises $11.9M to Advance Liquid Biopsy Platform
Dxcover received a grant of $2.7 million from the European Innovation Council to bring the total to near $12 million. Dxcover raised $11.9 million in combined series A and grant funding to โฆSee details»
Technology - Dxcover
A drop of blood serum is dried on a Dxcover® Slide and analyzed with infrared light. Data is captured from all the vital components, including the bodyโs response to disease. The Artificial โฆSee details»
Dxcover raises £9.7m in Series A investment and grant funding
Feb 1, 2023 Dxcoverโs novel liquid biopsy platform utilizes infrared spectroscopy to analyse patient blood samples and artificial intelligence algorithms to detect the presence or absence โฆSee details»
Cancer - Dxcover
The Dxcover liquid biopsy is a blood test for early detection of cancer. 90% of patients survive when cancer is found early. top of page. Technology. Science. Cancer. Brain cancer; News. โฆSee details»
Dxcover reveals $12M in new funding for multi-cancer early
Feb 3, 2023 Dxcover Ltd. raised $9.25 million (£7.5 million) in a series A fundraising round and received a grant of $2.7 million (£2.2 million) from the European Innovation Council to support โฆSee details»
News - Dxcover
May 29, 2024 Dxcover is a clinical stage liquid biopsy company developing tests for the early detection of multiple cancers, when treatment has a better chance to impact outcomes.See details»